ATP-binding cassette transporter A1, fatty acids, and cholesterol absorption

Current Opinion in Lipidology

Volumn 14, Issue 1, 2003, Pages 35-40

  Brousseau, Margaret E ^a,b  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TUFTS UNIVERSITY   (United States)

Author keywords

ATP binding cassette transporter A1 gene; Cholesterol absorption; Fatty acids; HDL

Indexed keywords

ABC TRANSPORTER; CHOLESTEROL; FATTY ACID; LIVER X RECEPTOR; RECEPTOR; UNCLASSIFIED DRUG;

ATHEROSCLEROSIS; CHOLESTEROL METABOLISM; GENE ACTIVITY; GENE EXPRESSION REGULATION; GENE FUNCTION; GENETIC TRANSCRIPTION; HUMAN; INTESTINE ABSORPTION; NONHUMAN; PRIORITY JOURNAL; REVIEW; TANGIER DISEASE;

ABSORPTION; ANIMALS; ARTERIOSCLEROSIS; ATP-BINDING CASSETTE TRANSPORTERS; CHOLESTEROL; DIETARY FATS; FATTY ACIDS; HUMANS;

EID: 0037312805     PISSN: 09579672     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041433-200302000-00007     Document Type: Review

References (31)

1. Glomset JA. The plasma lecithin:cholesterol acyltransferase reaction. J Lipid Res 1968; 9:155-167.
2. Bodzioch M, Orso E, Klucken J, et al. The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease. Nat Genet 1999; 22:347-351.
3. Brooks-Wilson A, Marcil M, Clee SM, et al. Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency. Nat Genet 1999; 22:336-345.
4. Rust S, Rosier M, Funke H, et al. Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1. Nat Genet 1999; 22:352-355.
5. Assmann G, von Eckardstein A, Brewer HB Jr. Familial high density lipoprotein deficiency: Tangier disease. In: Scriver CR, Beaudet AL, Sly WS, Valle D, editors. The metabolic and molecular basis of inherited disease. New York: McGraw-Hill; 1995. pp. 2053-2072.
6. Oram JF. ATP-binding cassette transporter A1 and cholesterol trafficking. Curr Opin Lipidol 2002; 13:373-381.
7. Langmann T, Klucken J, Reil M, et al. Molecular cloning of the human ATP-binding cassette transporter 1 (hABC1): evidence for sterol-dependent regulation in macrophages. Biochem Biophys Res Commun 1999; 257:29-33.
8. Costet P, Luo Y, Wang N, Tall AR. Sterol-dependent transactivation of the ABC1 promoter by the liver X receptor/retinoid X receptor. J Biol Chem 2000; 275:28240-28245.
9. Schwartz K, Lawn RM, Wade DP. ABC1 gene expression and apoA-I-mediated cholesterol efflux are regulated by LXR. Biochem Biophys Res Commun 2000; 274:794-802.
10. Venkateswaran A, Laffitte BA, Joseph SB, et al. Control of cellular cholesterol efflux by the nuclear oxysterol receptor LXR alpha. Proc Natl Acad Sci U S A 2000; 97:12097-12102.
11. Ou J, Tu H, Shan B, et al. Unsaturated fatty acids inhibit transcription of the sterol regulatory element-binding protein-1c (SREBP-1c) gene by antagonizing ligand-dependent activation of the LXR. Proc Natl Acad Sci U S A 2001; 96:6027-6032.
12. Repa JJ, Turley SD, Lobaccaro JA, et al. Regulation of absorption and ABC1-mediated efflux of cholesterol by RXR heterodimers. Science 2000; 289:1524-1529.
13. Berge KE, Tian H, Graf GA, et al. Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters. Science 2000; 290:1771-1775.
14. Wang Y, Oram JF. Unsaturated fatty acids inhibit cholesterol efflux from macrophages by increasing degradation of ATP-binding cassette transporter A1. J Biol Chem 2002; 277:5692-5697. This interesting study demonstrates that treatment of cultured murine macrophages with unsaturated fatty acids, in particular linoleate (18:2), causes a significant inhibition of the pathway of lipid efflux mediated by ABCA1.
15. Murthy S, Born E, Mathur SN, Field FJ. LXR/RXR activation enhances basolateral efflux of cholesterol in CaCo-2 cells. J Lipid Res 2002; 43:1054-1064. RXR and LXR agonists were found to increase expression of the ABC transporters A1 and G1 in Caco-2 cells, a human intestinal cell line. Moreover, treatment with RXR and LXR agonists enhanced apolipoprotein-mediated cholesterol efflux from the basolateral, but not apical, membranes of these cells.
16. Becq F, Hamon A, Bajetto M, et al. ABC1, an ATP binding cassette transporter required for phagocytosis of apoptotic cells, generates a regulated anion flux after expression in Xenopus laevis oocytes. J Biol Chem 1997; 272:2695-2699.
17. Ohama T, Hirano K, Zhang Z, et al. Dominant expression of ATP-binding cassette transporter-1 on basolateral surface of Caco-2 cells stimulated by LXR/RXR ligands. Biochem Biophys Res Commun 2002; 296:625-630.
18. Lee J, Shirk A, Oram JF, et al. Polarized cholesterol and phospholipid efflux in cultured gall-bladder epithelial cells: evidence for an ABCA1-mediated pathway. Biochem J 2002; 364:475-484. This study provides evidence for the involvement of an LXR/RXR-responsive ABC transporter in lipid efflux from gall bladder epithelial cells.
19. Plat J, Mensink RP. Increased intestinal ABCA1 expression contributes to the decrease in cholesterol absorption after plant stanol consumption. FASEB J 2002; 16:1248-1253.
20. Ikeda I, Tanabe Y, Sugano M. Effects of sitosterol and sitostanol on micellar solubility of cholesterol. J Nutr Sci Vitaminol 1989; 35:361-369.
21. Plat J, van Onselen ENM, van Heugten MMA, Mensink RP. Effects on serum lipids, lipoproteins and fat soluble antioxidant concentrations of consumption frequency of margarines and shortenings enriched with plant stanol esters. Eur J Clin Nutr 2000; 54:671-677.
22. McNeish J, Aiello RJ, Guyot D, et al. High density lipoprotein deficiency and foam cell accumulation in mice with targeted disruption of ATP-binding cassette transporter-1. Proc Natl Acad Sci U S A 2000; 97:4245-4250.
23. Drobnik W, Lindenthal B, Lieser B, et al. ATP-binding cassette transporter A1 (ABCA1) affects total body sterol metabolism. Gastroenterology 2001; 120:1203-1211. Relative to wild type mice, a significant reduction (-11%, P<0.001) in cholesterol absorption was observed in mice lacking the ABCA1 gene.
24. Schaefer EJ, Brousseau ME, Diffenderfer MR, et al. Cholesterol and apolipoprotein B metabolism in Tangier disease. Atherosclerosis 2001; 159:231-236. To date, this is the only published study to investigate cholesterol metabolism in a patient with mutations in the gene encoding ABCA1. In this Tangier disease patient, cholesterol absorption was normal.
25. Vaisman BL, Lambert G, Amar M, et al. ABCA1 overexpression leads to hyperalphalipoproteinemia and increased biliary cholesterol excretion in transgenic mice. J Clin Invest 2001; 108:303-309. This is the first study to report the effects of ABCA1 overexpression in mice. Overexpression of ABCA1 in the liver caused a significant increase in biliary cholesterol and phospholipid content, indicating that ABCA1 may facilitate the transport of these lipids into the bile.
26. Groen AK, Bloks VW, Bandsma RH, et al. Hepatobiliary cholesterol transport is not impaired in Abca1-null mice lacking HDL. J Clin Invest 2001; 108:843-850. The results of this study suggest that ABCA1 may not play an important role in hepatobiliary transport.
27. Plosch T, Kok T, Bloks VW, et al. Increased hepatobiliary and fecal cholesterol excretion upon activation of the liver X receptor is independent of ABCA1. J Biol Chem 2002; 277:33870-33877. In this study, treatment with an LXR agonist significantly increased the secretion of cholesterol, but not phospholipid, into the bile, of both ABCA1 knockout and wild type mice. Taken together with the results of their earlier work [26•], this report provides further evidence that the mechanism(s) responsible for the LXR-induced hypersecretion of cholesterol into the bile may be independent of ABCA1.
28. Repa JJ, Berge KE, Pomajzl C, et al. Regulation of ATP-binding cassette sterol transporters ABCG5 and ABCG8 by the liver X receptors alpha and beta. J Biol Chem 2002; 277:18793-18800.
29. Joyce CW, Amar MJ, Lambert G, et al. The ATP binding cassette transporter A1 (ABCA1) modulates the development of aortic atherosclerosis in C57BL/6 and apoE-knockout mice. Proc Natl Acad Sci U S A 2002; 99:407-412.
30. Singaraja RR, Fievet C, Castro G, et al. Increased ABCA1 activity protects against atherosclerosis. J Clin Invest 2002; 110:35-42.
31. Aiello RJ, Brees D, Bourassa P-A, et al. Increased atherosclerosis in hyperlipidemic mice with inactivation of ABCA1 in macrophages. Arterioscler Thromb Vasc Biol 2002; 22:630-637.